RIGI and bacterial infectious disease: Consistent with RIG-I initiation of protective responses, treatment with IFN-β significantly reduced the viability of both N. meningitidis and S. pneumoniae in all glial cell types (Figures 6C, F, I), reinforcing the protective function of type I IFNs during bacterial infection.